Vadim Jucaud

Dr. Vadim Jucaud

orcid

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 February 2023 in Advanced Functional Materials
Verified
Journal Article
Closed access
GGGang Ge
Gang Ge
KMKalpana Mandal
Kalpana Mandal
RHReihaneh Haghniaz
Reihaneh Haghniaz
MLMengchen Li
Mengchen Li
Xiao XiaoXiao Xiao
Xiao Xiao
Ali  KhademhosseiniAli Khademhosseini
Ali Khademhosseini

1 September 2021 in Current Opinion in Biomedical Engineering
Verified
Journal Article
Closed access
Yangzhi ZhuYangzhi Zhu
Yangzhi Zhu
KMKalpana Mandal
Kalpana Mandal
AHAna Lopez Hernandez
Ana Lopez Hernandez
SKSatoru Kawakita
Satoru Kawakita
WHWei Huang
Wei Huang
Ali  KhademhosseiniAli Khademhosseini
Ali Khademhosseini

6 October 2023 in Acta Biomaterialia
Verified
Journal Article
Closed access
NMNeda Mohaghegh
Neda Mohaghegh
AAAmir Ahari
Amir Ahari
FZFatemeh Zehtabi
Fatemeh Zehtabi
CBClaire Buttles
Claire Buttles
SDSaya Davani
Saya Davani
ANAlireza Hassani Najafabadi
Alireza Hassani Najafabadi

8 February 2019 in Hepatology
Verified
Journal Article
Closed access
PDF file
VJVadim Jucaud
Vadim Jucaud
ASAbraham Shaked
Abraham Shaked
MDMichele DesMarais
Michele DesMarais
PSPeter Sayre
Peter Sayre
SFSandy Feng
Sandy Feng
MEMatthew J. Everly
Matthew J. Everly

1 January 2024 in Bioactive Materials
Verified
Journal Article
Open access
Ehsan Nazarzadeh ZareEhsan Nazarzadeh Zare
Ehsan Nazarzadeh Zare
DKDanial Khorsandi
Danial Khorsandi
AZAtefeh Zarepour
Atefeh Zarepour
HYHulya Yilmaz
Hulya Yilmaz
Tarun AgarwalTarun Agarwal
Tarun Agarwal
Ali  KhademhosseiniAli Khademhosseini
Ali Khademhosseini
Heparin is a negatively charged polysaccharide with various chain lengths and a hydrophilic backbone. Due to its fascinating chemical and physical properties, nontoxicity, biocompatibility, and biodegradability, heparin has been extensively used in different fields of medicine, such as cardiovascular and hematology. This review highlights recent and future advancements in designing materials based on heparin for various biomedical applications. The physicochemical and mechanical properties, biocompatibility, toxicity, and biodegradability of heparin are discussed. In addition, the applications of heparin-based materials in various biomedical fields, such as drug/gene delivery, tissue engineering, cancer therapy, and biosensors, are reviewed. Finally, challenges, opportunities, and future perspectives in preparing heparin-based materials are summarized.

24 May 2017 in Journal of Immunology Research
Verified
Journal Article
Open access
PDF file
NENadim El-Awar
Nadim El-Awar
VJVadim Jucaud
Vadim Jucaud
ANAnh Nguyen
Anh Nguyen
Sensitization to human leukocyte antigens (HLA) in organ transplant patients causes graft rejection, according to the humoral theory of transplantation. Sensitization is almost ubiquitous as anti-HLA antibodies are found in almost all sera of transplant recipients. Advances in testing assays and amino acid sequencing of HLA along with computer software contributed further to the understanding of antibody-antigen reactivity. It is commonly understood that antibodies bind to HLA antigens. With current knowledge of epitopes, it is more accurate to describe that antibodies bind to their target epitopes on the surface of HLA molecular chains. Epitopes are present on a single HLA (private epitope) or shared by multiple antigens (public epitope). The phenomenon of cross-reactivity in HLA testing, often explained as cross-reactive groups (CREGs) of antigens with antibody, can be clearly explained now by public epitopes. Since 2006, we defined and reported 194 HLA class I unique epitopes, including 56 cryptic epitopes on dissociated HLA class I heavy chains, 83 HLA class II epitopes, 60 epitopes on HLA-DRB1, 15 epitopes on HLA-DQB1, 3 epitopes on HLA-DQA1, 5 epitopes on HLA-DPB1, and 7 MICA epitopes. In this paper, we provide a summary of our findings.